Integrated Risk Based Design and Global Regulatory Harmonization for Class IIb Medical Devices

Abstract

Medical devices that are considered moderate-high risk and hence demanding strict regulatory controls include Class IIb medical devices that have the potential to affect patient safety. With the growing interconnectivity and technological dependence of the healthcare system, the task of the manufacturers in managing conflicting regulatory frameworks in international jurisdiction has become extremely challenging. In spite of the fact that the majority of regulatory systems implement risk-based classification principles, the dissimilarity in clinical evidence requirements, documentation structures, and post-market surveillance requirements, generates complexity and redundancy in access to the global market. This review analyzes how the risk-based design principles have been integrated into the lifecycle of Class IIb medical devices and reviews current initiatives regarding global regulatory harmonization. It puts a stress on the role of structured risk management, design controls, human factor engineering, clinical evaluation, and post-market data integration in the delivery of device safety and performance. The paper also examines harmonization efforts by other bodies like the International Medical device regulators forum and discusses the mechanisms of reliance, common standards and models of lifecycle regulation as avenues to regulatory convergence. A risk-based harmonization structure is suggested, which integrates technical documentation alignment on a global level, alignment of the post-market intelligence systems, and reliance-based assessment strategies. New issues, such as artificial intelligence, cybersecurity, and vulnerabilities in the supply chain are covered as a priority that should be considered in the future during the evolution of regulations. Enhancing the connection between engineering risk management and global regulatory collaboration can provide a viable long-term approach to improving patient safety and helping to innovate Class IIb medical technologies.